The Androgenetic Alopecia Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for androgenetic alopecia treatment has experienced substantial growth, with the market size expected to rise from $2.29 billion in 2024 to $2.47 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.9%.
The Androgenetic Alopecia Treatment market is predicted to expand to a market size of $3.3 billion by 2029. The market is also anticipated to grow at a compound annual growth rate (CAGR) of 7.5%.
Download Your Free Sample of the 2025 Androgenetic Alopecia Treatment Market Report and Uncover Key Trends Now!The drivers in the androgenetic alopecia treatment market are:
• Rising incidence of hair loss
• High prevalence of chronic diseases such as cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis
• Increased demand for effective solutions to address hair loss concerns
• Surge in partnerships, product approvals, investments, and research and development activities.
The androgenetic alopecia treatment market covered in this report is segmented –
1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users
The trends in the androgenetic alopecia treatment market are:
• The occurrence of partnerships in the market is an emerging trend.
• There is a notable trend in the increase of product approvals.
• The sector is seeing a heightened trend of investments.
• Research and development activities in the sector are on the rise.
The major players in the androgenetic alopecia treatment market are:
• Johnson & Johnson
• Merck & Co
North America was the largest region in the androgenetic alopecia treatment market in 2023